Discover 533 paid clinical trials in Memphis, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 533
Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma
Study Of Cold Cap Therapy For Prevention of Hairloss in Pediatric Patients Receiving Chemotherapy For Non-Malignant Indications and Solid Tumors
for
Alopecia
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital
Sex: All
Age: 7+
Code: NCT04764357
Recruiting
Sickle Cell Clinical Research and Intervention Program
for
Sickle Cell Disease
Location: Memphis TN, Peoria IL, Charlotte NC
Sponsor: St. Jude Children's Research Hospital
Sex: All
Age: 0+
Code: NCT02098863
Recruiting
Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
for
Sickle Cell Disease (SCD)
Location: Memphis TN, Birmingham AL, Atlanta GA, Indianapolis IN,
Sponsor: University of Rochester
Sex: All
Age: 3 - 20
Code: NCT06941389
Recruiting
Peripheral Arterial Tonometry and Neurocognition in Sickle Cell Disease
for
Sickle Cell Disease
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital
Sex: All
Age: 12 - 25
Code: NCT06477289
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Protocol For Collecting Data On Patients With Childhood Cancer
for
Childhood Cancer
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital
Sex: All
Age: 0+
Code: NCT00684580
Recruiting
A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia
for
Leukemia, Juvenile Myelomonocytic, JMML, JCML,
Location: Memphis TN, Atlanta GA, Kansas City MO, Indianapolis IN,
Sponsor: Therapeutic Advances in Childhood Leukemia Consortium
Sex: All
Age: 0 - 21
Code: NCT05849662
Phase 1, Phase 2, Recruiting
Ziftomenib in Combination With Chemotherapy for Children With Relapsed/Refractory Acute Leukemia
for
Relapsed/Refractory KMT2A-r Acute Leukemia,
Location: Memphis TN, Atlanta GA, Cincinnati OH, Chicago IL,
Sponsor: PedAL BCU, LLC
Sex: All
Age: 0 - 21
Code: NCT06376162
Phase 1, Recruiting
Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors
for
High Grade Glioma, CNS Tumor
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital
Sex: All
Age: 0 - 3
Code: NCT06528691
Phase 2, Recruiting
Study of Oral and Long-Acting Injectable Cabotegravir and Rilpivirine in Virologically Suppressed Children Living With HIV-1, Two to Less Than 12 Years of Age
for
HIV-1-infection
Location: Memphis TN, Atlanta GA
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 2 - 11
Code: NCT05660980
Phase 1, Phase 2, Recruiting
Targeted Therapy to Increase RAI Uptake in Metastatic DTC
for
Papillary Thyroid Cancer, Pediatric Cancer,
Location: Memphis TN, Atlanta GA, Houston TX, Philadelphia PA,
Sponsor: Children's Hospital of Philadelphia
Sex: All
Age: 0+
Code: NCT05024929
Recruiting
Embryonal Tumor With Multilayered Rosettes
for
Embryonal Tumor With Multilayered Rosettes,
Location: Memphis TN, Birmingham AL, St Louis MO, Indianapolis IN,
Sponsor: University of California, San Francisco
Sex: All
Age: 0+
Code: NCT06861244
Phase 2, Recruiting
Long Term Follow-Up Study for Individuals With Hemoglobin Disorders After Hematopoietic Cell Transplant or Gene Therapy
for
Hemoglobin Disorder
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital
Sex: All
Age: 0+
Code: NCT06646640
Recruiting
Study of CD19 Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ Leukemia
for
Acute Lymphoblastic Leukemia, in Relapse,
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital
Sex: All
Age: 0 - 21
Code: NCT04881240
Phase 1, Recruiting
Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia
for
Refractory Acute Myeloid Leukemia,
Location: Memphis TN, Atlanta GA, Kansas City MO, Cincinnati OH,
Sponsor: St. Jude Children's Research Hospital
Sex: All
Age: 1 - 30
Code: NCT06177067
Phase 1, Recruiting
Patient-Reported Outcomes and Quality of Life in Adult and Pediatric Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)